Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPhoenix Group Holdings Regulatory News (PHNX)

  • There is currently no data for PHNX

Board Changes

25 Aug 2016 07:00

RNS Number : 0802I
Phoenix Group Holdings
25 August 2016
 

 

Phoenix Group Holdings - Board Changes

 

The Board of Phoenix Group Holdings ("Phoenix") is pleased to announce the appointments of three new non-executive directors, Wendy Mayall, John Pollock and Nicholas Shott, all with effect from 1 September 2016.

 

Wendy Mayall has over thirty years' asset management experience, including as Group Chief Investment Officer and latterly consultant at Liverpool Victoria from 2012 to 2015, having previously been Chief Investment Officer for Unilever's UK pension fund from 1996 to 2011 and holding management responsibility for Unilever's pension funds globally. From 2006 to 2009, she was the Chair of the Investment Committee of the Mineworkers Pension Scheme, a British government appointment to one of the largest government backed pension schemes in the UK. Mrs Mayall is the non-executive Senior Independent Director of the Aberdeen UK Tracker Trust plc.

 

John Pollock had a highly successful career in life assurance at the Legal & General Group from 1980 to 2015, including as an executive director of Legal & General Group plc from 2003 to 2015. He held numerous senior roles, gaining wide strategic and technical experience, finally as Chief Executive Officer of LGAS (L&G Assurance Society), one of Legal and Generals' three primary business units, employing 6,000 staff. His previous roles included Chief Executive Officer (Protection and Annuities). Prior to his retirement from Legal and General in 2015, Mr Pollock held positions as Deputy Chair of the FCA Practitioner Panel, Chairman of investment platform Cofunds, and as a non-executive director of the Cala Homes Group.

 

Nicholas Shott is a highly experienced investment banker, who is European Vice Chairman of Lazard, a role he has held since 2007, and Head of UK Investment Banking at Lazard, which he has been since 2009. He joined Lazard in 1991 and became a partner in 1997. His wide experience of successfully advising clients on M&A deals in various sectors over many years is expected to be of significant benefit to Phoenix in pursuing its acquisition strategy.

 

The Phoenix Board also announces that Rene-Pierre Azria will be leaving the Board on 30 November 2016 after seven years as a non-executive director.

 

Commenting on the Board changes, Henry Staunton, Phoenix Chairman said: "I am delighted that we have secured the appointments to the Phoenix Board of three such experienced and successful individuals who will enhance the Board skillset in both quality and diversity. I would like to thank Rene-Pierre Azria for his valuable contribution to Phoenix since his appointment to the Board in September 2009 and through its progress as a premium listed company from July 2010. On behalf of all the Board, I wish him well."

 

No other information is required to be notified under Listing Rule 9.6.13 R.

 

Enquiries:

MediaNeil Bennett, MaitlandPeter Ogden, Maitland+ 44 (0) 20 7379 5151

InvestorsSam Perowne, Head of Investor Relations, Phoenix Group+44 (0) 203 735 0021

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAPIMLTMBITBBF
Date   Source Headline
17th May 20216:15 pmRNSHolding(s) in Company
14th May 20212:15 pmRNSResult of AGM
13th May 20219:00 amRNSDirector/PDMR Shareholding
30th Apr 202111:45 amRNSTotal Voting Rights
13th Apr 20211:00 pmRNSDirector/PDMR Shareholding
7th Apr 20211:00 pmRNSDirector/PDMR Shareholding
1st Apr 202112:00 pmRNSDirector/PDMR Shareholding
31st Mar 20212:00 pmRNSTotal Voting Rights
31st Mar 20212:00 pmRNSDirector/PDMR Shareholding
30th Mar 202110:00 amRNSDirector/PDMR Shareholding
30th Mar 202110:00 amRNSDirector/PDMR Shareholding
29th Mar 20214:40 pmRNSNotice of AGM
24th Mar 20214:15 pmRNSDirector/PDMR Shareholding
19th Mar 202111:30 amRNSDirector/PDMR Shareholding
18th Mar 202110:00 amRNSHolding(s) in Company
17th Mar 20212:00 pmRNSDirector/PDMR Shareholding
17th Mar 20212:00 pmRNSDirector/PDMR Shareholding
17th Mar 20212:00 pmRNSDirector/PDMR Shareholding
16th Mar 20214:30 pmRNSDirector/PDMR Shareholding
8th Mar 20213:15 pmRNSDirector/PDMR Shareholding
8th Mar 20217:00 amRNS2020 Annual Financial Results
26th Feb 20212:00 pmRNSTotal Voting Rights
23rd Feb 20217:00 amRNSPhoenix and SLA simplify Strategic Partnership
23rd Feb 20217:00 amRNSUpdate on Strategic Partnership with PGH
8th Feb 20216:00 pmRNSDirector/PDMR Shareholding
29th Jan 20213:30 pmRNSTotal Voting Rights
21st Jan 20214:45 pmRNSHolding(s) in Company
8th Jan 20213:10 pmRNSDirector/PDMR Shareholding
31st Dec 202011:00 amRNSTotal Voting Rights
29th Dec 202010:45 amRNSHolding(s) in Company
24th Dec 20207:00 amRNSHolding(s) in Company
18th Dec 20203:30 pmRNSBlock listing Return
11th Dec 20202:45 pmRNSDirector/PDMR Shareholding
9th Dec 20204:00 pmRNSDirector/PDMR Shareholding
3rd Dec 20207:00 amRNSPhoenix Group Holdings plc - Trading Update
30th Nov 20204:00 pmRNSTotal Voting Rights
24th Nov 20207:00 amRNSStatement Regarding Press Speculation
6th Nov 20205:30 pmRNSDirector/PDMR Shareholding
6th Nov 20204:15 pmRNSDirector/PDMR Shareholding
30th Oct 202012:30 pmRNSTotal Voting Rights
28th Oct 20205:30 pmRNSDirector/PDMR Shareholding
28th Oct 202010:30 amRNSNotice of Delisting of Restricted Tier 1 Notes
27th Oct 20202:48 pmRNSNotice of Variation and Relisting of Notes
14th Oct 20209:40 amRNSHolding(s) in Company
7th Oct 202012:15 pmRNSDirector/PDMR Shareholding
7th Oct 202012:15 pmRNSDirector/PDMR Shareholding
6th Oct 202012:45 pmRNSDirector/PDMR Shareholding
1st Oct 20201:00 pmRNSDirector/PDMR Shareholding
30th Sep 202012:20 pmRNSTotal Voting Rights
25th Sep 202011:45 amRNSPublication of a Prospectus

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.